Nazila Kamaly

MAGfect: a novel liposome formulation for MRI labelling and visualization of cells.

Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging.

Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.

Imaging of gadolinium spatial distribution in tumor tissue by laser ablation inductively coupled plasma mass spectrometry.

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI.

Chemistry of tumour targeted T1 based MRI contrast agents.

Paramagnetic liposome nanoparticles for cellular and tumour imaging.

A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.

Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo.

Synthesis and characterization of a theranostic vascular disrupting agent for in vivo MR imaging.

Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents.

CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging.

Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting.

Simultaneous Cross-Linking and Cross-Polymerization of Enzyme Responsive Polyethylene Glycol Nanogels in Confined Aqueous Droplets for Reduction of Low-Density Lipoprotein Oxidation.

Ac2-26-Nanoparticles Induce Resolution of Intestinal Inflammation and Anastomotic Healing via Inhibition of NF-κB Signaling in a Model of Perioperative Colitis.

Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm.

Nanoparticle protein corona evolution: from biological impact to biomarker discovery.

Nanoconfined anti-oxidizing RAFT nitroxide radical polymer for reduction of low-density lipoprotein oxidation and foam cell formation.

Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy.

Advancements in nanomedicines for the detection and treatment of diabetic kidney disease.

Nanodrug delivery systems for metabolic chronic liver diseases: advances and perspectives.

Magnetic iron oxide nanogels for combined hyperthermia and drug delivery for cancer treatment.

Orally delivered biodegradable targeted inflammation resolving pectin-coated nanoparticles induce anastomotic healing post intestinal surgery.

Redox-Responsive Polymeric Nanogels as Efficient mRNA Delivery Vehicles in .

Long-Lasting Cross-Linked PLGA-Inspired Nanoparticles from One-Pot Nanopolymerization of Precisely Sequenced Short Oligolactoglycolic Acid Dimethacrylates.

Precise intracellular uptake and endosomal release of diverse functional mRNA payloads via glutathione-responsive nanogels.